BiotechTube
Home/Renalytix/James McCullough
JM

James McCullough

Chief Executive Officer, Co-Founder

Renalytix

Therapeutic Areas

Kidney DiseaseDiabetic Kidney DiseaseCardiorenal Syndrome

Renalytix Pipeline

DrugIndicationPhase
KidneyIntelX.dkdProgressive decline in kidney function in adults with Type 2 Diabetes and CKD Stages 1-3bCommercial
KidneyIntelX in Heart FailureRisk of worsening kidney function in patients with heart failureDevelopment
KidneyIntelX for CKD EtiologyDisease sub-typing and causation in broad CKD populationResearch

Leadership Team at Renalytix

FF
Fergus Fleming
Chief Technology Officer, Co-Founder
HD
Howard Doran
President
JR
Joel R. Jung
Interim Chief Financial Officer
MJ
Michael J. Donovan
Chief Medical Officer
View full Renalytix profile